羚锐制药
(600285)
| 流通市值：107.52亿 | | | 总市值：107.64亿 |
| 流通股本：5.66亿 | | | 总股本：5.67亿 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 2,147,977,056.01 | 1,126,074,496.05 | 3,853,391,129.7 | 3,041,361,639.17 |
| 营业总成本 | 1,588,839,181.41 | 848,497,974.23 | 3,029,670,519.08 | 2,332,076,667.21 |
| 其他经营收益 | | | | |
| 营业利润 | 578,865,226.33 | 285,253,602.85 | 887,273,905.67 | 758,364,587.13 |
| 利润总额 | 577,310,999.69 | 285,511,916.89 | 879,465,631.28 | 757,558,792.81 |
| 净利润 | 497,854,676.89 | 247,441,910.98 | 762,447,855.85 | 653,536,523.2 |
| 每股收益 | | | | |
| 其他综合收益 | -51,004,009.56 | -71,032.45 | 42,390,202.71 | 4,885,283.79 |
| 综合收益总额 | 446,850,667.33 | 247,370,878.53 | 804,838,058.56 | 658,421,806.99 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 2,837,917,042.29 | 2,566,464,708.69 | 2,279,888,243.92 | 2,574,106,317.5 |
| 非流动资产: | | | | |
| 非流动资产合计 | 2,917,685,356.18 | 3,399,220,128.59 | 3,355,618,696.34 | 3,181,581,407.38 |
| 资产总计 | 5,755,602,398.47 | 5,965,684,837.28 | 5,635,506,940.26 | 5,755,687,724.88 |
| 流动负债: | | | | |
| 流动负债合计 | 2,407,925,953.68 | 2,191,225,278.11 | 2,115,579,452.25 | 2,393,537,389.61 |
| 非流动负债: | | | | |
| 非流动负债合计 | 77,922,147.1 | 89,134,126.91 | 84,013,302.51 | 78,865,018.23 |
| 负债合计 | 2,485,848,100.78 | 2,280,359,405.02 | 2,199,592,754.76 | 2,472,402,407.84 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 3,231,633,873.95 | 3,648,870,888.17 | 3,400,583,878.89 | 3,248,239,730.07 |
| 股东权益合计 | 3,269,754,297.69 | 3,685,325,432.26 | 3,435,914,185.5 | 3,283,285,317.04 |
| 负债和股东权益合计 | 5,755,602,398.47 | 5,965,684,837.28 | 5,635,506,940.26 | 5,755,687,724.88 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 2,247,158,335.81 | 1,048,573,124.1 | 3,925,891,376.75 | 3,108,738,229.97 |
| 经营活动现金流出小计 | 1,523,818,255.28 | 780,122,968.49 | 3,372,008,662.96 | 2,618,350,573.61 |
| 经营活动产生的现金流量净额 | 723,340,080.53 | 268,450,155.61 | 553,882,713.79 | 490,387,656.36 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 1,554,038,191.91 | 432,522,777.32 | 1,493,318,038.35 | 722,196,602.94 |
| 投资活动现金流出小计 | 1,279,471,694.12 | 531,131,261.23 | 2,679,444,946.96 | 1,916,478,880.54 |
| 投资活动产生的现金流量净额 | 274,566,497.79 | -98,608,483.91 | -1,186,126,908.61 | -1,194,282,277.6 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | 352,026,773.58 | 64,245,955.83 | 371,250,790.47 | 517,374,558.27 |
| 筹资活动现金流出小计 | 989,051,101.71 | 164,028,641 | 584,513,307.64 | 582,179,320.3 |
| 筹资活动产生的现金流量净额 | -637,024,328.13 | -99,782,685.17 | -213,262,517.17 | -64,804,762.03 |
| 汇率变动对现金及现金等价物的影响 | -26,748.84 | -9,302.68 | -27,150.54 | -22,131.92 |
| 现金及现金等价物净增加额 | 360,855,501.35 | 70,049,683.85 | -845,533,862.53 | -768,721,515.19 |
| 期末现金及现金等价物余额 | 743,699,444.82 | 452,893,627.32 | 382,843,943.47 | 459,656,290.81 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 360,855,501.35 | - | -845,533,862.53 | - |
最新报告期：2026-08-28| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中信建投 | 刘若飞,沈兴熙,贺菊颖 | 1.48 | 1.66 | 1.86 | 2026-08-28 |
| 招商证券 | 梁广楷,欧阳京,许菲菲 | 1.45 | 1.62 | 1.79 | 2026-08-25 |
| 东海证券 | 杜永宏 | 1.50 | 1.68 | 1.86 | 2026-08-21 |
| 首创证券 | 王斌 | 1.44 | 1.62 | 1.82 | 2026-08-20 |
| 兴业证券 | 孙媛媛,董晓洁,黄翰漾 | 1.44 | 1.61 | 1.79 | 2026-08-15 |